← Back to all trials
Suspended
NCT07760324
CD4 Cell Count at Antiretroviral Therapy Initiation or Re- Initiation
Conditions: HIV - Human Immunodeficiency Virus
Sex: All
Ages: 18 Years – 99 Years
Healthy volunteers: No
Enrollment: 151
Sponsor: Centre for Infectious Disease Research in Zambia
Location: Chawama Lusaka Lusaka Province
Summary
The primary purpose of this study is to assess the burden of advanced HIV disease (CD4 cell count \
Eligibility Criteria
Inclusion Criteria:
* All adults aged ≥18 years who are willing and able to provide consent and are: newly enrolling in HIV care and starting ART at study sites OR
* re-enrolling after a known ≥24-month ART gap confirmed by clinic records or patient recall at eligibility screening.
Exclusion Criteria:
* Patients known to be on ART for more than 7 days at the time of assessment for enrollment into study.
* Patients with a gap in ART that is \
Source: ClinicalTrials.gov (NCT07760324). StuddyBuddy aggregates publicly available trial information.
